New Cancer Vaccine Keeps Melanoma From Returning in Trial

A personalized vaccine combined with existing cancer treatment stopped skin cancer from coming back in over 1,000 patients during a major clinical trial.

Scientists used the same mRNA technology from COVID vaccines to create custom treatments targeting each patient's unique tumor.